Can vitamin e tame COVID-19 inflammation? early trial hints yes
Symptom relief
Completed
This early-phase study tested whether high doses of vitamin E (alpha-tocopherol) could reduce C-reactive protein (CRP), a marker of inflammation, in 56 adults with COVID-19. Participants were randomly assigned to receive vitamin E or a placebo. The results suggest that vitamin E …
Phase: EARLY_PHASE1 • Sponsor: Universidad Veracruzana • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC